Establishment Labs (NASDAQ:ESTA) Stock Price Up 4.1%


Share on StockTwits

Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s share price rose 4.1% on Thursday . The company traded as high as $73.40 and last traded at $73.40. Approximately 135 shares changed hands during trading, a decline of 100% from the average daily volume of 106,239 shares. The stock had previously closed at $70.50.

ESTA has been the subject of a number of research analyst reports. BTIG Research raised their price objective on Establishment Labs from $41.00 to $61.00 and gave the company a “buy” rating in a research report on Wednesday, January 13th. Zacks Investment Research lowered Establishment Labs from a “buy” rating to a “hold” rating in a research report on Thursday, March 11th. Finally, Cowen raised their price objective on Establishment Labs from $60.00 to $80.00 and gave the company an “outperform” rating in a research report on Wednesday, February 10th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $47.60.

The company has a market cap of $1.63 billion, a PE ratio of -40.94 and a beta of 1.15. The company has a debt-to-equity ratio of 0.62, a current ratio of 6.65 and a quick ratio of 5.24. The company has a 50-day moving average of $63.98 and a 200 day moving average of $43.36.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings results on Tuesday, March 9th. The company reported ($0.23) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.19) by ($0.04). Establishment Labs had a negative return on equity of 49.51% and a negative net margin of 46.40%. Equities research analysts expect that Establishment Labs Holdings Inc. will post -1.23 EPS for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Lazard Asset Management LLC lifted its stake in Establishment Labs by 19.4% in the fourth quarter. Lazard Asset Management LLC now owns 2,633 shares of the company’s stock worth $99,000 after purchasing an additional 427 shares during the last quarter. BlackRock Inc. lifted its stake in Establishment Labs by 96.9% in the third quarter. BlackRock Inc. now owns 8,357 shares of the company’s stock worth $155,000 after purchasing an additional 4,113 shares during the last quarter. Squarepoint Ops LLC bought a new stake in Establishment Labs in the third quarter worth about $208,000. Trexquant Investment LP bought a new stake in Establishment Labs in the fourth quarter worth about $229,000. Finally, Tudor Investment Corp Et Al bought a new stake in Establishment Labs in the fourth quarter worth about $303,000. 54.80% of the stock is owned by institutional investors and hedge funds.

Establishment Labs Company Profile (NASDAQ:ESTA)

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution.

Read More: How Do You Calculate Return on Equity (ROE)?

Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.